Carbamazepine
- Product NDC
- 60505-2805
- 11-digit product format
- 605052805
- Labeler code
- 60505
- Product ID
- 60505-2805_697610a8-e6e7-b0d0-ef1b-2507d5b73c53
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbamazepine
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Apotex Corp.
- Application
- ANDA078986
- Marketing category
- ANDA
- Marketing start
- 2012-03-23
- Substance
- CARBAMAZEPINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Carbamazepine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CARBAMAZEPINE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 33CM23913M |
| Rxcui | 200131, 200133, 388311 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60505-2805-3 | Carbamazepine | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | | 15 |
| 60505-2805-7 | Carbamazepine | 120 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 120 | | 15 |
| 60505-2805-8 | Carbamazepine | 1000 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 1000 | | 15 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CARBAMAZEPINE | ACTIVE INGREDIENT | 33CM23913M | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| CARBAMAZEPINE | ACTIVE MOIETY | 33CM23913M | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| ETHYLCELLULOSE (7 MPA.S) | INACTIVE INGREDIENT | H3UP11403C | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-2805 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 14 | Current NDC, Legacy NDC, 3 package rows | 20240922_e91f9de3-3fdd-0a6b-71ce-53a2cc142816.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-2805-3 | 60505280503 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-2805-3) | 2012-03-23 | 2023-03-31 | No | No | Current |
| 60505-2805-7 | 60505280507 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-2805-7) | 2012-03-23 | 2023-03-31 | No | No | Current |
| 60505-2805-8 | 60505280508 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-2805-8) | 2012-03-23 | 2023-03-31 | No | No | Current |